Skip to main content

Table 2 Quality of life in hypertensive patients-summary of each domain

From: Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Quality of Life assessment domains

STEP I

STEP II

Baseline

n (Mean ± SD)

Baseline

n (Mean ± SD)

4 weeks or less

n (Mean ± SD)

Over 4 weeks

n (Mean ± SD)

General Health Domain (GH)

12,184 (3.3 ± 1.0)

2014 (3.1 ± 1.0)

25 (3.0 ± 1.1)

1989 (3.1 ± 1.0)

Physical Domain (PD)

12,183 (16.8 ± 5.4)

2013 (16.1 ± 5.2)

25 (16.4 ± 4.9)

1988 (16.1 ± 5.2)

Mental Domain (MD)

12,183 (17.9 ± 5.4)

2014 (17.5 ± 5.1)

25 (17.6 ± 4.8)

1989 (17.5 ± 5.1)

Social Domain (SD)

12,182 (24.4 ± 4.8)

2014 (23.4 ± 4.9)

25 (22.4 ± 5.3)

1989 (23.5 ± 4.9)

Hypertension Domain (HTN)

12,181 (21.8 ± 7.0)

2013 (21.2 ± 6.4)

25 (21.7 ± 5.5)

1988 (21.2 ± 6.4)

Total Scores

12,177 (84.1 ± 18.5)

2012 (81.3 ± 17.4)

25 (81.1 ± 16.8)

1987 (81.3 ± 17.4)